Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis

  1. Smith, L.
  2. Serrano, D.R.
  3. Mauger, M.
  4. Bolás-Fernández, F.
  5. Dea-Ayuela, M.A.
  6. Lalatsa, A.
Journal:
Molecular Pharmaceutics

ISSN: 1543-8392,  1543-8384

Year of publication: 2018

Volume: 15

Issue: 7

Pages: 2570-2583

Type: Article

DOI: 10.1021/ACS.MOLPHARMACEUT.8B00097 GOOGLE SCHOLAR
Data source: Scopus